⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 27, 2024Diabetes Obesity and MetabolismOpen Access

[P³]PP, a stable, long‐acting pancreatic polypeptide analogue, evokes weight lowering and pancreatic beta‐cell‐protective effects in obesity‐associated diabetes

Neil Tanday Wuyun Zhu Andrei I. Tarasov Peter R. Flatt Nigel Irwin

View Full Paper

Ask AI

Bookmark

Share

Abstract

To thoroughly investigate the impact of sustained neuropeptide Y4 receptor (NPY4R) activation in obesity-associated diabetes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tanday et al. (2024) studied this question.

synapsesocial.com/papers/68e5ab9cb6db643587545c2b https://doi.org/10.1111/dom.15897

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Novel enzyme‐resistant pancreatic polypeptide analogs evoke pancreatic beta‐cell rest, enhance islet cell turnover, and inhibit food intake in mice2024 · 7 citations
2PYY3‐36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in micepreclinical · 2013 · 35 citations
3The PTPN1/N2 Peptide Inhibitor Achieves Potent, Long-Acting Glycemic Control and Weight-Loss Dual Efficacy in MiceOriginal Research · 2026
4Illuminating the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective2024 · 6 citations
5<scp>G</scp><scp>LP</scp>‐1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea2024 · 9 citations